Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31

Gudmundur Gudmundsson1, Stefan E Matthiasson, Haukur Arason

  • 1deCODE Genetics, Reykjavik, Iceland.

Insights

Researchers identified a specific gene locus, PAOD1 on chromosome 1p31, linked to peripheral arterial occlusive disease (PAOD). This finding suggests distinct genetic factors may contribute to vascular disease subtypes.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Epidemiology

Background:

  • Peripheral arterial occlusive disease (PAOD) stems from atherosclerosis in major arteries, sharing risk factors like smoking, diabetes, hypertension, and hyperlipidemia with coronary and cerebrovascular diseases.
  • PAOD often presents concurrently with other cardiovascular and cerebrovascular conditions, indicating potential shared underlying mechanisms.

Purpose of the Study:

  • To investigate the genetic underpinnings of peripheral arterial occlusive disease (PAOD) within the Icelandic population.
  • To identify potential genetic loci associated with PAOD through a genomewide scan.

Main Methods:

  • A population-based cohort of 272 Icelandic PAOD patients, identified through angiography/revascularization records, was cross-matched with a national genealogy database.
  • A genomewide scan utilizing microsatellite markers was performed on 116 extended families.
  • Linkage analysis was conducted, including an analysis excluding patients with a history of stroke to refine locus identification.

Main Results:

  • Significant linkage to chromosome 1p31 was detected, designated as PAOD1, with an allele-sharing LOD score of 3.93.
  • Excluding patients with a history of stroke strengthened the linkage, increasing the LOD score to 4.93.
  • The results indicate a specific genetic locus associated with PAOD.

Conclusions:

  • A novel genetic locus, PAOD1 on chromosome 1p31, is significantly associated with peripheral arterial occlusive disease.
  • The findings suggest the existence of genetic factors specific to PAOD, distinct from those contributing to other vascular diseases like stroke, despite shared risk factors.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...